{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:46Z","timestamp":1740107686901,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10067-022-06437-z","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T21:02:49Z","timestamp":1668200569000},"page":"807-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A bibliometric analysis of idiopathic inflammatory myopathies from 1982 to 2021"],"prefix":"10.1007","volume":"42","author":[{"given":"Teng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1342-4518","authenticated-orcid":false,"given":"Zhenhua","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"issue":"12","key":"6437_CR1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F et al (2018) Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75(12):1528\u20131537. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2598","journal-title":"JAMA Neurol"},{"issue":"5","key":"6437_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14(5):269\u2013278. https:\/\/doi.org\/10.1038\/nrrheum.2018.41","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"6437_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17(9):816\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"issue":"5","key":"6437_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst DE, Amato AA, Iorga SR, Gajria K, Fernandes AW (2012) Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 45(5):676\u2013683. https:\/\/doi.org\/10.1002\/mus.23302","journal-title":"Muscle Nerve"},{"issue":"8","key":"6437_CR5","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.3346\/jkms.2019.34.e55","volume":"34","author":"S-K Cho","year":"2019","unstructured":"Cho S-K, Kim H, Myung J, Nam E, Jung S-Y, Jang EJ et al (2019) Incidence and prevalence of idiopathic inflammatory myopathies in Korea: a nationwide population-based study. J Korean Med Sci 34(8):e55. https:\/\/doi.org\/10.3346\/jkms.2019.34.e55","journal-title":"J Korean Med Sci"},{"issue":"5","key":"6437_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","volume":"56","author":"J Svensson","year":"2017","unstructured":"Svensson J, Arkema EV, Lundberg IE, Holmqvist M (2017) Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study. Rheumatol 56(5):802\u2013810. https:\/\/doi.org\/10.1093\/rheumatology\/kew503","journal-title":"Rheumatol"},{"issue":"1","key":"6437_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primer 7(1):86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primer"},{"issue":"2","key":"6437_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.55563\/clinexprheumatol\/vskjxi","volume":"40","author":"C Cardelli","year":"2022","unstructured":"Cardelli C, Zanframundo G, Cometi L, Marcucci E, Biglia A, Cavagna L et al (2022) Idiopathic inflammatory myopathies: one year in review 2021. Clin Exp Rheumatol 40(2):199\u2013209. https:\/\/doi.org\/10.55563\/clinexprheumatol\/vskjxi","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"6437_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14(5):290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"6437_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63(3):713\u2013721. https:\/\/doi.org\/10.1002\/art.30156","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6437_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/BOR.0000000000000106","volume":"26","author":"AL Mammen","year":"2014","unstructured":"Mammen AL (2014) Necrotizing myopathies: beyond statins. Curr Opin Rheumatol 26(6):679\u2013683. https:\/\/doi.org\/10.1097\/BOR.0000000000000106","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"6437_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Araguas","year":"2012","unstructured":"Trallero-Araguas E, Rodrigo-Pendas JA, Selva-O\u2019Callaghan A, Martinez-Gomez X, Bosch X, Labrador-Horrillo M et al (2012) Usefulness of anti-P155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64(2):523\u2013532. https:\/\/doi.org\/10.1002\/art.33379","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6437_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M et al (2012) Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 64(2):513\u2013522. https:\/\/doi.org\/10.1002\/art.33403","journal-title":"Arthritis Rheum"},{"key":"6437_CR14","doi-asserted-by":"publisher","first-page":"7991031","DOI":"10.1155\/2022\/7991031","volume":"2022","author":"P Deng","year":"2022","unstructured":"Deng P, Shi H, Pan X, Liang H, Wang S, Wu J et al (2022) Worldwide research trends on diabetic foot ulcers (2004-2020): suggestions for researchers. J Diabetes Res 2022:7991031. https:\/\/doi.org\/10.1155\/2022\/7991031","journal-title":"J Diabetes Res"},{"key":"6437_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jconrel.2022.03.031","volume":"345","author":"C Peng","year":"2022","unstructured":"Peng C, Kuang L, Zhao J, Ross AE, Wang Z, Ciolino JB (2022) Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020. J Control Release 345:625\u2013645. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.031","journal-title":"J Control Release"},{"key":"6437_CR16","doi-asserted-by":"publisher","first-page":"800499","DOI":"10.3389\/fonc.2022.800499","volume":"12","author":"Y Shi","year":"2022","unstructured":"Shi Y, Luo J, Wang X, Zhang Y, Zhu H, Su D et al (2022) Emerging trends on the correlation between neurotransmitters and tumor progression in the last 20 years: a bibliometric analysis via CiteSpace. Front Oncol 12:800499. https:\/\/doi.org\/10.3389\/fonc.2022.800499","journal-title":"Front Oncol"},{"key":"6437_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tifs.2021.12.033","volume":"120","author":"D Xavier-Santos","year":"2022","unstructured":"Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K et al (2022) Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: a bibliometric analysis and systematic review. Trends Food Sci Technol 120:174\u2013192. https:\/\/doi.org\/10.1016\/j.tifs.2021.12.033","journal-title":"Trends Food Sci Technol"},{"issue":"1","key":"6437_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11657-021-00929-2","volume":"16","author":"H Wu","year":"2021","unstructured":"Wu H, Li Y, Tong L, Wang Y, Sun Z (2021) Worldwide research tendency and hotspots on hip fracture: a 20-year bibliometric analysis. Arch Osteoporos 16(1):73. https:\/\/doi.org\/10.1007\/s11657-021-00929-2","journal-title":"Arch Osteoporos"},{"issue":"2","key":"6437_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523\u2013538. https:\/\/doi.org\/10.1007\/s11192-009-0146-3","journal-title":"Scientometrics"},{"issue":"4","key":"6437_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00296-022-05097-1","volume":"42","author":"X Zhang","year":"2022","unstructured":"Zhang X, Yang Q, Yu H, Yin F, He Y, Peng L et al (2022) Bibliometric analysis of the global literature productivity of adult-onset Still\u2019s disease (2011-2020). Rheumatol Int 42(4):707\u2013716. https:\/\/doi.org\/10.1007\/s00296-022-05097-1","journal-title":"Rheumatol Int"},{"issue":"9","key":"6437_CR21","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s10067-022-06196-x","volume":"41","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zheng B, Hong J, Liu Y (2022) Mapping theme trends and knowledge structure of Sj\u00f6gren\u2019s syndrome (SS), a bibliometric analysis from 2010 to 2021. Clin Rheumatol 41(9):2779\u20132789. https:\/\/doi.org\/10.1007\/s10067-022-06196-x","journal-title":"Clin Rheumatol"},{"issue":"22","key":"6437_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/BRS.0000000000001393","volume":"42","author":"G Fan","year":"2017","unstructured":"Fan G, Han R, Zhang H, He S, Chen Z (2017) Worldwide research productivity in the field of minimally invasive spine surgery: a 20-year survey of publication activities. Spine 42(22):1717\u20131722. https:\/\/doi.org\/10.1097\/BRS.0000000000001393","journal-title":"Spine"},{"issue":"7331","key":"6437_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(64)90792-5","volume":"1","author":"JN Walton","year":"1964","unstructured":"Walton JN (1964) Some diseases of muscle. Lancet 1(7331):447\u2013452","journal-title":"Lancet"},{"issue":"18","key":"6437_CR24","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372(18):1734\u20131747. https:\/\/doi.org\/10.1056\/NEJMra1402225","journal-title":"N Engl J Med"},{"issue":"9","key":"6437_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(19)30200-5","volume":"18","author":"MG Hanna","year":"2019","unstructured":"Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H et al (2019) Safety and efficacy of intravenous bimagrumab in inclusion body myositis (resilient): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol 18(9):834\u2013844. https:\/\/doi.org\/10.1016\/S1474-4422(19)30200-5","journal-title":"Lancet Neurol"},{"issue":"5","key":"6437_CR26","first-page":"820","volume":"34","author":"M Amaral Silva","year":"2016","unstructured":"Amaral Silva M, Cogollo E, Isenberg DA (2016) Why do patients with myositis die? A retrospective analysis of a single-centre cohort. Clin Exp Rheumatol 34(5):820\u2013826","journal-title":"Clin Exp Rheumatol"},{"key":"6437_CR27","doi-asserted-by":"publisher","first-page":"290797","DOI":"10.1155\/2014\/290797","volume":"2014","author":"M Labrador-Horrillo","year":"2014","unstructured":"Labrador-Horrillo M, Martinez MA, Selva-O\u2019Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M et al (2014) Anti-MDA5 antibodies in a large mediterranean population of adults with dermatomyositis. J Immunol Res 2014:290797. https:\/\/doi.org\/10.1155\/2014\/290797","journal-title":"J Immunol Res"},{"issue":"4","key":"6437_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","volume":"50","author":"F Romero-Bueno","year":"2020","unstructured":"Romero-Bueno F, Diaz Del Campo P, Trallero-Araguas E, Ruiz-Rodriguez JC, Castellvi I, Rodriguez-Nieto MJ et al (2020) Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Semin Arthritis Rheum 50(4):776\u2013790. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.007","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"6437_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","volume":"14","author":"CV Oddis","year":"2018","unstructured":"Oddis CV, Aggarwal R (2018) Treatment in myositis. Nat Rev Rheumatol 14(5):279\u2013289. https:\/\/doi.org\/10.1038\/nrrheum.2018.42","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"6437_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S (2019) Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med 381(3):291\u2013293. https:\/\/doi.org\/10.1056\/NEJMc1900045","journal-title":"N Engl J Med"},{"issue":"12","key":"6437_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-019-0878-x","volume":"21","author":"M Klein","year":"2019","unstructured":"Klein M, Mann H, Vencovsky J (2019) Arthritis in idiopathic inflammatory myopathies. Curr Rheumatol Rep 21(12):70. https:\/\/doi.org\/10.1007\/s11926-019-0878-x","journal-title":"Curr Rheumatol Rep"},{"issue":"32","key":"6437_CR32","doi-asserted-by":"publisher","first-page":"e1144","DOI":"10.1097\/MD.0000000000001144","volume":"94","author":"L Cavagna","year":"2015","unstructured":"Cavagna L, Nuno L, Scire CA, Govoni M, Longo FJL, Franceschini F et al (2015) Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine 94(32):e1144. https:\/\/doi.org\/10.1097\/MD.0000000000001144","journal-title":"Medicine"},{"issue":"6","key":"6437_CR33","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3899\/jrheum.131223","volume":"41","author":"M Klein","year":"2014","unstructured":"Klein M, Mann H, Plestilova L, Betteridge Z, McHugh N, Remakova M et al (2014) Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations. J Rheumatol 41(6):1133\u20131139. https:\/\/doi.org\/10.3899\/jrheum.131223","journal-title":"J Rheumatol"},{"issue":"7","key":"6437_CR34","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00296-011-1931-x","volume":"32","author":"A Nakajima","year":"2012","unstructured":"Nakajima A, Yoshino K, Soejima M, Kawaguchi Y, Satoh T, Kuwana M et al (2012) High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis. Rheumatol Int 32(7):2057\u20132061. https:\/\/doi.org\/10.1007\/s00296-011-1931-x","journal-title":"Rheumatol Int"},{"issue":"35","key":"6437_CR35","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","volume":"38","author":"ALP Caforio","year":"2017","unstructured":"Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M et al (2017) Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial disease. Eur Heart J 38(35):2649\u20132662. https:\/\/doi.org\/10.1093\/eurheartj\/ehx321","journal-title":"Eur Heart J"},{"issue":"3","key":"6437_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2017.12.001","volume":"17","author":"KS Lee","year":"2018","unstructured":"Lee KS, Kronbichler A, Eisenhut M, Lee KH, Shin JI (2018) Cardiovascular involvement in systemic rheumatic diseases: an integrated view for the treating physicians. Autoimmun Rev 17(3):201\u2013214. https:\/\/doi.org\/10.1016\/j.autrev.2017.12.001","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6437_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2013.11.059","volume":"171","author":"S Mavrogeni","year":"2014","unstructured":"Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E et al (2014) Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol 171(1):82\u201387. https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.059","journal-title":"Int J Cardiol"},{"issue":"11","key":"6437_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.jcmg.2017.12.008","volume":"11","author":"CP Kotanidis","year":"2018","unstructured":"Kotanidis CP, Bazmpani M-A, Haidich A-B, Karvounis C, Antoniades C, Karamitsos TD (2018) Diagnostic accuracy of cardiovascular magnetic resonance in acute myocarditis: a systematic review and meta-analysis. JACC Cardiovasc Imaging 11(11):1583\u20131590. https:\/\/doi.org\/10.1016\/j.jcmg.2017.12.008","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"6437_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/rheumatology\/keab573","volume":"61","author":"JL Fairley","year":"2021","unstructured":"Fairley JL, Wicks I, Peters S, Day J (2021) Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Rheumatol 61(1):103\u2013120. https:\/\/doi.org\/10.1093\/rheumatology\/keab573","journal-title":"Rheumatol"},{"key":"6437_CR40","doi-asserted-by":"publisher","first-page":"1759720X1988649","DOI":"10.1177\/1759720X19886494","volume":"12","author":"S Glaubitz","year":"2020","unstructured":"Glaubitz S, Zeng R, Schmidt J (2020) New insights into the treatment of myositis. Ther Adv Musculoskelet Dis 12:1759720X19886494. https:\/\/doi.org\/10.1177\/1759720X19886494","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"8","key":"6437_CR41","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H, Stjarne J, Stenseth G, Grovle L et al (2015) Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis 74(8):1551\u20131556. https:\/\/doi.org\/10.1136\/annrheumdis-2013-205127","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6437_CR42","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/ard.2008.093161","volume":"68","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D et al (2009) Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 68(7):1192\u20131196. https:\/\/doi.org\/10.1136\/ard.2008.093161","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6437_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","volume":"77","author":"JB Lilleker","year":"2018","unstructured":"Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J et al (2018) The Euromyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30\u201339. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6437_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/BOR.0000000000000327","volume":"28","author":"O Molberg","year":"2016","unstructured":"Molberg O, Dobloug C (2016) Epidemiology of sporadic inclusion body myositis. Curr Opin Rheumatol 28(6):657\u2013660. https:\/\/doi.org\/10.1097\/BOR.0000000000000327","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"6437_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/ene.12627","volume":"22","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjarne J et al (2015) High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol 22(4):672\u2013e41. https:\/\/doi.org\/10.1111\/ene.12627","journal-title":"Eur J Neurol"},{"issue":"2","key":"6437_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaad.2021.07.003","volume":"86","author":"MS Min","year":"2022","unstructured":"Min MS, Alsarheed A, Kassamali B, Mazori DR, Schaefer M, Merola JF et al (2022) Tofacitinib as treatment for refractory dermatomyositis: a retrospective study from 2 academic medical centers. J Am Acad Dermatol 86(2):423\u2013425. https:\/\/doi.org\/10.1016\/j.jaad.2021.07.003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"6437_CR47","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/rheumatology\/keab629","volume":"61","author":"H Zhang","year":"2022","unstructured":"Zhang H, Sun Y, Liu H, Cheng X, Ye J, Hu Q et al (2022) Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series. Rheumatol 61(6):2625\u20132630. https:\/\/doi.org\/10.1093\/rheumatology\/keab629","journal-title":"Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06437-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06437-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06437-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T09:08:39Z","timestamp":1676538519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06437-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6437"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06437-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"24 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}